NASDAQ:OXFD - Oxford Immunotec Global Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $22.00
  • Forecasted Upside: 0.05 %
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$21.99
+0.30 (1.20%)
Get New Oxford Immunotec Global Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for OXFD and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for OXFD

Analyst Price Target is $22.00
▲ +0.05% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Oxford Immunotec Global in the last 3 months. The average price target is $22.00, with a high forecast of $22.00 and a low forecast of $22.00. The average price target represents a 0.05% upside from the last price of $21.99.

This chart shows the closing price for OXFD for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 2 contributing investment analysts is to hold stock in Oxford Immunotec Global. This rating has held steady since September 2020, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/5/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/3/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/2/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
3/2/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
5/31/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
8/29/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
10/28/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
11/27/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/7/2021JPMorgan Chase & Co.DowngradeOverweight ➝ NeutralMedium
1/7/2021Piper SandlerDowngradeOverweight ➝ Neutral$24.00 ➝ $22.00N/A
12/18/2020Piper SandlerBoost Price TargetOverweight$18.00 ➝ $24.00High
9/24/2019CowenSet Price TargetBuy$20.00Low
9/18/2019Piper Jaffray CompaniesSet Price TargetBuy$20.00Low
3/8/2019Piper Jaffray CompaniesInitiated CoverageOverweightLow
11/11/2018Piper Jaffray CompaniesReiterated RatingOverweightLow
5/1/2018BTIG ResearchSet Price TargetBuy$19.00Medium
1/22/2018CowenReiterated RatingBuy$15.00High
12/18/2017BTIG ResearchSet Price TargetBuy$21.00Medium
11/1/2017Robert W. BairdReiterated RatingBuy$20.00N/A
10/31/2017BTIG ResearchSet Price TargetBuy$21.00N/A
10/31/2017Piper Jaffray CompaniesLower Price TargetOverweight$26.00 ➝ $19.00N/A
9/28/2017CowenReiterated RatingBuy$19.00High
9/28/2017BTIG ResearchInitiated CoverageBuy ➝ Buy$21.00High
8/17/2017CowenLower Price TargetOutperform$22.00 ➝ $19.00Low
8/3/2017CowenReiterated RatingBuy$22.00Low
8/3/2017Piper Jaffray CompaniesReiterated RatingBuy$26.00Low
5/4/2017BTIG ResearchReiterated RatingBuyMedium
3/10/2017BTIG ResearchReiterated RatingBuy$19.00N/A
(Data available from 11/27/2016 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/1/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/31/2021
  • 0 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/30/2021
  • 2 very positive mentions
  • 10 positive mentions
  • 3 negative mentions
  • 1 very negative mentions
7/30/2021
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/29/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/28/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/28/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/27/2021

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Oxford Immunotec Global logo
Oxford Immunotec Global PLC, a diagnostics company, focuses on developing and commercializing proprietary tests for immunology and infectious diseases in the United States, Europe, Asia, and internationally. The company develops its products using its T-SPOT technology platform that measures marker-specific cellular (T cells) responses at a single cell level and inform the diagnosis, prognosis, and monitoring of patients with immune-regulated conditions. It develops and markets T-SPOT.TB test used to test for tuberculosis; and reagents and methods to purify white blood cells for use in immunology assays. In addition, the company offers T-SPOT.CMV, an immune monitoring test for cytomegalovirus (CMV) for the quantification of effector T cells that respond to stimulation by antigens specific for CMV, as well as for the monitoring of CMV-seropositive responses in transplant recipients at various time-points post-transplantation applications. It serves independent laboratories, hospital systems, and public and private institutions. Oxford Immunotec Global PLC was founded in 2002 and is headquartered in Abingdon, the United Kingdom.
Read More

Today's Range

Now: $21.99
Low: $21.99
High: $21.99

50 Day Range

MA: $21.98
Low: $21.88
High: $21.99

52 Week Range

Now: $21.99
Low: $8.37
High: $23.11

Volume

N/A

Average Volume

1,099,251 shs

Market Capitalization

$570.90 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.42

Frequently Asked Questions

What sell-side analysts currently cover shares of Oxford Immunotec Global?

The following Wall Street research analysts have issued stock ratings on Oxford Immunotec Global in the last twelve months: JPMorgan Chase & Co., and Piper Sandler.
View the latest analyst ratings for OXFD.

What is the current price target for Oxford Immunotec Global?

1 Wall Street analysts have set twelve-month price targets for Oxford Immunotec Global in the last year. Their average twelve-month price target is $22.00, suggesting a possible upside of 0.0%. Piper Sandler has the highest price target set, predicting OXFD will reach $22.00 in the next twelve months. Piper Sandler has the lowest price target set, forecasting a price of $22.00 for Oxford Immunotec Global in the next year.
View the latest price targets for OXFD.

What is the current consensus analyst rating for Oxford Immunotec Global?

Oxford Immunotec Global currently has 2 hold ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in OXFD, but not buy more shares or sell existing shares.
View the latest ratings for OXFD.

What other companies compete with Oxford Immunotec Global?

How do I contact Oxford Immunotec Global's investor relations team?

Oxford Immunotec Global's physical mailing address is 94C INNOVATION DRIVE MILTON PARK, ABINGDON X0, OX14 4RZ. The company's listed phone number is 44-0-12-3544-2780 and its investor relations email address is [email protected] The official website for Oxford Immunotec Global is www.oxfordimmunotec.com.